Kwality Pharmaceuticals Surges 8.14%: 7 Key Developments Fueling the Rally
2026-11-21 14:00:06Key Events This Week 16 Nov: Stock surges 5.86% to Rs.4,048.75 on strong momentum 18 Nov: New 52-week high at Rs.4,235 and all-time high near Rs.4,189.80 19 Nov: Hits fresh 52-week and all-time high at Rs.4,274.75 20 Nov: Upgraded to Buy rating by MarketsMOJO amid strong fundamentals Week OpenRs.3,824.45 Week Close<di...
Read More
Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 4,274.75 as Momentum Builds Across Timeframes
2026-11-19 09:36:35Extending its remarkable rally, Kwality Pharmaceuticals Ltd touched a fresh all-time high of Rs 4,274.75 on 19 Nov 2026, marking a significant milestone in its market journey. This surge comes amid sustained outperformance against the broader Sensex and a bullish technical backdrop.
Read More
Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals
2026-11-19 08:05:03Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a strong daily moving average and positive monthly indicators despite some bearish weekly signals. The stock’s recent surge to ₹4,195.25, up 3.76% on the day, reflects renewed investor confidence amid mixed technical readings.
Read More
Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 4235
2026-11-18 15:36:25Surging from a 52-week low of Rs 851.95 to a new peak of Rs 4235, Kwality Pharmaceuticals Ltd has delivered an extraordinary 344.61% return over the past year, vastly outperforming the Sensex’s decline of 3.12%. This remarkable rally culminated in a fresh 52-week high on 18 Nov 2026, driven predominantly by a confluence of strong technical signals and sustained price momentum.
Read More
Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 4,217.40 as Momentum Builds Across Timeframes
2026-11-18 15:18:15Extending its remarkable rally, Kwality Pharmaceuticals Ltd surged 4.31% on 18 Nov 2026 to touch a fresh all-time high of Rs 4,217.40, significantly outpacing the Sensex which declined 0.61% on the same day.
Read More
Kwality Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Strong Price Momentum
2026-11-17 08:03:20Kwality Pharmaceuticals Ltd has exhibited a notable shift in price momentum, with its share price surging over 5.8% in a single day to ₹4,048.75. Despite this robust price action, technical indicators present a nuanced picture, reflecting a transition from a bullish to a mildly bullish trend. Investors and analysts are closely monitoring these mixed signals to gauge the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.
Read More
Kwality Pharmaceuticals Ltd is Rated Buy
2026-11-15 10:10:29Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreKwality Pharmaceuticals Gains 4.92%: 6 Key Factors Driving the Week’s Momentum
2026-11-14 13:01:41Key Events This Week Nov 09: New 52-week high at Rs.3,880 Nov 11: All-time high reached at Rs.3,930 Nov 12: New 52-week and all-time high at Rs.4,065.90 Nov 13: Week closes at Rs.3,824.45 (-2.99% on day) Week OpenRs.3,645.05 Week CloseRs.3,824.45+4.92%</d...
Read More
375% Return in One Year, 115% Profit Growth: What Drives Kwality Pharmaceuticals Ltd’s Multibagger Surge?
2026-11-11 18:25:04A 375.49% stock return in one year. Net profit growth of 114.93% over the same period. The gap between these two figures highlights a significant rerating of Kwality Pharmaceuticals Ltd, with the market paying a much higher multiple for its earnings. This analysis explores how much of the rally is grounded in fundamentals and what the valuation metrics reveal about the sustainability of this surge.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
16-Nov-2026 | Source : BSETranscript of Earnings Conference Call - Q2FY2027
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14-Nov-2026 | Source : BSEIntimation under Regulation 30 of the SEBI (LODR)
Corporate Actions
No Upcoming Board Meetings
Kwality Pharmaceuticals Ltd has declared 6% dividend, ex-date: 05 Jan 17
No Splits history available
Kwality Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 11 Oct 17
No Rights history available